Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 7/8/2026 | Sell | Torley, Helen | PRESIDENT AND CEO | $79.7 | $153,391 |
| 7/1/2026 | Sell | Connaughton, Bernadette | Director | $76.8 | $124,651 |
| 6/29/2026 | Sell | Krishnan, Mahesh | Director | $75.0 | $547,800 |
| 6/3/2026 | Sell | Torley, Helen | PRESIDENT AND CEO | $68.1 | $690,653 |
| 6/2/2026 | Sell | Torley, Helen | PRESIDENT AND CEO | $66.5 | $1,327,745 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)